Top Abstract Purchase Related
Home
>
Node
>
Subnode

Thalidomide in the treatment of refractory rheumatoid arthritis

Keesal, N.; Wasserman, M.J.; Bookman, A.; Lapp, V.; Weber, D.A.; Keystone, E.C.

Journal of Rheumatology 26(11): 2344-2347

1999

ISSN/ISBN: 0315-162X
PMID: 10555888
Document Number: 506139
Objective. To review outcomes in 10 patients with rheumatoid arthritis (RA) treated with thalidomide. Methods. We reviewed our experience with 10 patients treated with thalidomide using a standard therapeutic protocol and standard outcome measures. Results. We observed no significant improvement in any outcome measure, likely as a consequence of the limited duration of therapy related to thalidomide toxicity. Conclusion. Formal studies of the efficacy of thalidomide in RA are required with alternative doses of the compound used by us, or with compounds derived from other sources.

Document emailed within 1 workday
Secure & encrypted payments

O'Reilly, T.J. 1977: Azathioprine in the treatment of refractory rheumatoid arthritis Irish Medical Journal 70(11): 344-346
Chevallard, M.; Venegoni, C.; Scaramuzza, D.; Carrabba, M.; Colombo, B. 1988: Pilot study on the use of captopril in treatment of refractory rheumatoid arthritis Giornale di Clinica Medica 69(6-7): 443-445; 447
Nakamura, H.; Yoshino, S.; Ishiuchi, N.; Fujimori, J.; Kanai, T.; Nishimura, Y. 1997: Outcome of radical multiple synovectomy as a novel surgical treatment for refractory rheumatoid arthritis: implication of HLA-DRB1*0405 in post-operative results Clinical and Experimental Rheumatology 15(1): 53-57
Davis, J.C.; Fessler, B.J.; Tassiulas, I.O.; McInnes, I.B.; Yarboro, C.H.; Pillemer, S.; Wilder, R.; Fleisher, T.A.; Klippel, J.H.; Boumpas, D.T. 1998: High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis Journal of Rheumatology 25(9): 1694-1704
Zuo, X.-X.; Gong, Y.-H.; Zhou, Y.-O.; Luo, H.; Xiao, X.-Z. 2008: The plasmic translocation and release of high mobility group box chromosomal protein 1 in peripheral blood monocytes of patients with rheumatoid arthritis and the effect of thalidomide Zhonghua Nei Ke Za Zhi 47(5): 374-377
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Allanore, Y.; Sellam, J.; Batteux, F.; Job Deslandre, C.; Weill, B.; Kahan, A. 2004: Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab Clinical and Experimental Rheumatology 22(6): 756-758
Grana, J.; Mahia, I.V.; Meizoso, M.-O.S.; Vazquez, T. 2008: Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis) Clinical and Experimental Rheumatology 26(2): 384-385
Maksymowych, W.P.; Aviña-Zubieta, A.; Luong, M.; Russell, A.S. 1996: High dose intravenous immunoglobulin (IVIg) in severe refractory rheumatoid arthritis: no evidence for efficacy Clinical and Experimental Rheumatology 14(6): 657-660
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
De Bosset, P.L.; Biter, T. 1973: Near-cytotoxic gold salt therapy in long standing drug-refractory rheumatoid arthritis. a prospective investigation Schweizerische Medizinische Wochenschrift 103(33): 1153-1158
Hansen, M.; Hansen, P.B. 2006: Refractory anaemia successfully treated with thalidomide Ugeskrift for Laeger 168(6): 591-592
Revaz, S.; Dudler, J. 2008: Diagnosis and treatment of rheumatoid vasculitis and other systemic complications of rheumatoid arthritis Revue Medicale Suisse 4(149): 712; 714 716-717
Langdon, C.G.; Moran, D.G.; Jamieson, V.; Spence, S.; Hill, S.A. 1990: A multicentre study of tenoxicam for the treatment of osteo-arthritis and rheumatoid arthritis in general practice Journal of International Medical Research 18(6): 489-496
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542